Skip to content

The INCA study: a study into the Impact of Nutrition on Children with Attention-Deficit Hyperactivity Disorder (ADHD)

A Dutch randomised controlled trial into the effects of food on the behaviour of a random group of school-going children meeting the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for Attention-Deficit Hyperactivity Disorder (ADHD), including immunological testing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76063113
Enrollment
100
Registered
2008-01-07
Start date
2008-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-deficit hyperactivity disorder (ADHD) Mental and Behavioural Disorders Disturbance of activity and attention

Interventions

Current interventions as of 23/09/2008: All children will be randomly assigned to either a diet group or a control group. Each group consists of 50 children. From each child at least two blood samples

Sponsors

Wageningen University (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ADHD diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV); diagnoses based on structured psychiatric interviews and standard questionnaires (Abbreviated Conners Scale, ADHD Rating Scale, Strengths and Difficulties Questionnaire) to be completed by parents and teachers 2. Children aged between 4 and 8 3. Children not taking medication such as methylphenidate 4. Parental permission for three blood tests 5. Sufficient command of the Dutch language

Exclusion criteria

Exclusion criteria: 1. Family circumstances hampering completion of the elimination diet 2. Children already on a diet or having been on a diet in the past two months 3. Children receiving behavioural therapy or medication at the time of registration

Design outcomes

Primary

MeasureTime frame
The Abbreviated Conners Scale (ACS) and the ADHD Rating Scale (ARS) are the two major rating scales for the outcomes of this study. They will be used during all measurement points, i.e. M1 (week 0), M2 (week 3), M3 (week 9), M4 (week 11) and M5 (week 13). 1. The ACS consists of 10 questions using a 4-point scale. A score of 15 represents two standard deviations above the mean cut-off. Scores can range from 0 to 30. The ACS will be completed by both the parents and the teacher 2. The ARS is based on the DSM-IV and consists of 9 inattention items and 9 hyperactivity/impulsivity items, and uses a 4-point scale. The answers to each question vary from Never or Rarely (0 points), Sometimes (1 point), Often (2 points) to Very Often (3 points). The ARS will be completed by the parents, teachers and the blinded paediatrician

Secondary

MeasureTime frame
1. A Structured Psychiatric Interview (SPI), based on DSM-IV criteria, will be used to assess comorbid disorders, like ODD and CD. This interview is taken at M1 (week 0), M3 (week 9) and M5 (week 13) and will be completed by the parents, the teacher and the blinded paediatrician 2. The Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire, concerning emotional and conduct problems, hyperactivity/inattention, peer relationship and prosocial behaviour. The answers to each question are Not True, Somewhat True or Certainly True. Parents and the child?s teacher will fill in the SDQ at M2 (week 3), M3 (week 9) and M5 (week 13) 3. Physical complaints of the child will be identified with the Other Complaints Questionnaire. The questions concern the presence or absence of physical complaints such as gastrointestinal problems, headaches, eczema, unusual perspiration, sleep disturbances and asthma. The answers to each question are Yes (often complaints) or No (seldom or never complaints). Parents must fill in the questionnaire at M2 (week 3), M3 (week 9) and M5 (week 13) 4. All IgG-scores, IgE-scores and other blood values will be analysed

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026